| Paul E Vassil, MD | |
|
2320 Rothsville Rd, Suite 200, Lititz, PA 17543-8215 | |
| (717) 721-4800 | |
| (717) 626-1613 |
| Full Name | Paul E Vassil |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 32 Years |
| Location | 2320 Rothsville Rd, Lititz, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821023730 | NPI | - | NPPES |
| 1517912 | Medicaid | PA | |
| VA692219 | Other | PA | BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD053079L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayada Home Health Care, Inc. | Philadelphia, PA | Home health agency |
| Wellspan Vna Home Care | York, PA | Home health agency |
| Wellspan Ephrata Community Hospital | Ephrata, PA | Hospital |
| Lancaster General Hospital | Lancaster, PA | Hospital |
| Good Samaritan Hospital | Lebanon, PA | Hospital |
| York Hospital | York, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellspan Medical Group | 1951213115 | 1946 |
News Archive
Parkinson's disease (PD) is a well-studied neurodegenerative disorder that affects between 7 and 10 million people worldwide.
Test system on Drosophila should provide the key to histone function. The genetic inherited material DNA was long viewed as the sole bearer of hereditary information. The function of its packaging proteins, the histones, was believed to be exclusively structural. Additional genetic information can be stored, however, and passed on to subsequent generations through chemical changes in the DNA or histones. Scientists from the Max Planck Institute for Biophysical Chemistry in Göttingen have succeeded in creating an experimental system for testing the function of such chemical histone modifications and their influence on the organism.
Physicians have long observed that binge drinking can significantly impair the healing process following a bone fracture.
Trubion Pharmaceuticals, Inc. today announced Pfizer's decision to discontinue development of TRU-015 (PF-05212374), an investigational drug in Phase 2 evaluation for the treatment of rheumatoid arthritis (RA) developed under the companies' CD20 collaboration. However, Pfizer has confirmed that it will continue to develop SBI-087 (PF-05230895), Trubion's next-generation, humanized, subcutaneous CD20 RA product candidate also in Phase 2 clinical evaluation.
› Verified 2 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
Parkinson's disease (PD) is a well-studied neurodegenerative disorder that affects between 7 and 10 million people worldwide.
Test system on Drosophila should provide the key to histone function. The genetic inherited material DNA was long viewed as the sole bearer of hereditary information. The function of its packaging proteins, the histones, was believed to be exclusively structural. Additional genetic information can be stored, however, and passed on to subsequent generations through chemical changes in the DNA or histones. Scientists from the Max Planck Institute for Biophysical Chemistry in Göttingen have succeeded in creating an experimental system for testing the function of such chemical histone modifications and their influence on the organism.
Physicians have long observed that binge drinking can significantly impair the healing process following a bone fracture.
Trubion Pharmaceuticals, Inc. today announced Pfizer's decision to discontinue development of TRU-015 (PF-05212374), an investigational drug in Phase 2 evaluation for the treatment of rheumatoid arthritis (RA) developed under the companies' CD20 collaboration. However, Pfizer has confirmed that it will continue to develop SBI-087 (PF-05230895), Trubion's next-generation, humanized, subcutaneous CD20 RA product candidate also in Phase 2 clinical evaluation.
› Verified 2 days ago
| Entity Name | Ephrata Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1427195379 PECOS PAC ID: 4981514445 Enrollment ID: O20040419000747 |
News Archive
Parkinson's disease (PD) is a well-studied neurodegenerative disorder that affects between 7 and 10 million people worldwide.
Test system on Drosophila should provide the key to histone function. The genetic inherited material DNA was long viewed as the sole bearer of hereditary information. The function of its packaging proteins, the histones, was believed to be exclusively structural. Additional genetic information can be stored, however, and passed on to subsequent generations through chemical changes in the DNA or histones. Scientists from the Max Planck Institute for Biophysical Chemistry in Göttingen have succeeded in creating an experimental system for testing the function of such chemical histone modifications and their influence on the organism.
Physicians have long observed that binge drinking can significantly impair the healing process following a bone fracture.
Trubion Pharmaceuticals, Inc. today announced Pfizer's decision to discontinue development of TRU-015 (PF-05212374), an investigational drug in Phase 2 evaluation for the treatment of rheumatoid arthritis (RA) developed under the companies' CD20 collaboration. However, Pfizer has confirmed that it will continue to develop SBI-087 (PF-05230895), Trubion's next-generation, humanized, subcutaneous CD20 RA product candidate also in Phase 2 clinical evaluation.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul E Vassil, MD 2320 Rothsville Rd, Suite 200, Lititz, PA 17543-8215 Ph: (717) 721-4800 | Paul E Vassil, MD 2320 Rothsville Rd, Suite 200, Lititz, PA 17543-8215 Ph: (717) 721-4800 |
News Archive
Parkinson's disease (PD) is a well-studied neurodegenerative disorder that affects between 7 and 10 million people worldwide.
Test system on Drosophila should provide the key to histone function. The genetic inherited material DNA was long viewed as the sole bearer of hereditary information. The function of its packaging proteins, the histones, was believed to be exclusively structural. Additional genetic information can be stored, however, and passed on to subsequent generations through chemical changes in the DNA or histones. Scientists from the Max Planck Institute for Biophysical Chemistry in Göttingen have succeeded in creating an experimental system for testing the function of such chemical histone modifications and their influence on the organism.
Physicians have long observed that binge drinking can significantly impair the healing process following a bone fracture.
Trubion Pharmaceuticals, Inc. today announced Pfizer's decision to discontinue development of TRU-015 (PF-05212374), an investigational drug in Phase 2 evaluation for the treatment of rheumatoid arthritis (RA) developed under the companies' CD20 collaboration. However, Pfizer has confirmed that it will continue to develop SBI-087 (PF-05230895), Trubion's next-generation, humanized, subcutaneous CD20 RA product candidate also in Phase 2 clinical evaluation.
› Verified 2 days ago
Jeffrey R Gerard, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6 W Newport Rd, Lititz, PA 17543 Phone: 717-627-2108 | |
Thomas W Andersen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 562 W 2nd Ave, Lititz, PA 17543 Phone: 717-626-2167 Fax: 717-626-1915 | |
John D Ginder, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 116b W Airport Rd, Lititz, PA 17543 Phone: 717-581-9000 | |
Dr. Linda Michelle Wilson, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1500 Highlands Dr, Lititz, PA 17543 Phone: 717-625-5000 | |
Dr. Ryan Christopher Wennell, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 51 Peters Rd Ste 200-201, Lititz, PA 17543 Phone: 717-626-2167 Fax: 717-626-1915 | |
Douglas R Morrissey, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6 W Newport Rd, Lititz, PA 17543 Phone: 717-627-2108 | |
Regina M Martin, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2320 Rothsville Rd, Suite 200, Lititz, PA 17543 Phone: 717-721-4800 Fax: 717-626-1613 |